Schedule 13G ownership disclosure

Puma Biotechnology Inc

Security class unavailable · CUSIP: 74587V107

Event date: 2016-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,212,105
Percent of class
6.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000812295-17-000094
Form type
SC 13G
Filer
JANUS HENDERSON INVESTORS US LLC
CIK
CIK 812295
Filed
Feb 13, 2017
Reporting period
Dec 31, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub